The 20 Best Severe Congenital Neutropenia Doctors Near Me in Ann Arbor, MI

Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is rated as an Advanced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.

Monalisa Ghosh, MD, Assistant Professor. Dr. Ghosh graduated with honors from the University of Alabama at Birmingham with a BS in Biomedical Engineering, minor in Mathematics and Chemistry. She earned her MD from the University of Alabama School of Medicine where she also completed her residency training. Her fellowship training was completed at the NIH/NCI Medical Oncology Fellowship Program. Dr. Ghosh’s research interest is in bone marrow trans-plantation and cellular therapies to treat lymphoma. Dr. Ghosh will be seeing patients on the BMT service. Dr. Ghosh is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Graft Versus Host Disease (GvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Colonoscopy.

Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Burke is board certified in Hematology and Medical Oncology.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Dr. Jeffrey Smerage is a hematologist/oncologist specializing in breast cancer. He received both a medical and doctoral degree from the University of Florida and then went on to residency training at the University of Virginia. In 2004, after completing a fellowship in hematology and oncology at the University of Michigan, Dr. Smerage joined the faculty of the Department of Internal Medicine and began his practice in the Breast Care Center. Dr. Smerage is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Smerage is board certified in Medical Oncology and Clinical Informatics.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.

Dr. Norah Lynn Henry is a medical oncologist, Associate Director of Community Outreach and Engagement at the Rogel Cancer Center, and Co-Chair of the Symptom Management and Survivorship Committee for the SWOG Cancer Research Network.Dr. Henry specializes in the care of patients with all stages and all types of breast cancer. Her research focuses on personalizing treatment for breast cancer. She studies treatments for breast cancer as well as ways to manage symptoms and side effects that arise from the cancer or its treatment. Her goal is to provide effective treatments for breast cancer while maintaining the quality of life of each patient. In addition, she works with scientists at the University of Michigan to translate their lab findings into clinical trials. Dr. Henry is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Henry is board certified in Medical Oncology.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

Languages: English, Spanish Activities: Running, Cycling. Awards:2023 Castle Connolly Top Doctor. Dr. Pianko is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, and Bone Marrow Transplant. Dr. Pianko is board certified in Internal Medicine, Hematology, and Medical Oncology.

Arathi Mohan is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Mohan is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Stomach Cancer. Dr. Mohan is board certified in Internal Medicine and Medical Oncology.

Oxana Crysler is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Crysler is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Crysler is board certified in Medical Oncology.

Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Ganglioneuroblastoma, Rhabdomyosarcoma, Rhabdoid Tumor Predisposition Syndrome, and Rhabdoid Tumor.

Scott Schuetze is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.

Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors. Dr. Morikawa is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is board certified in Internal Medicine and Medical Oncology.

Dr. Schott is a Professor of Medicine and is the Associate Director of Clinical Research for the Rogel Cancer Center. She is an expert in the field of breast cancer, has an active breast cancer practice, and frequently gives lectures and publishes about breast cancer treatment. Her research is focused on the development of new treatments for breast cancer, and the testing of these treatments in clinical trials. Dr. Schott is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, HER2 Negative Breast Cancer, and Tissue Biopsy.

Dr. Burness is driven by a desire to improve therapies for breast cancer patients. Her research arises from her clinical experiences in treating breast cancer patients. Her research focus is on the development of therapies to target cancer stem cells, specifically ways to alter DNA repair mechanisms and inflammation in cancer stem cells. This innovative approach to treating breast cancer holds promise for identifying new therapeutic targets and improving therapeutic regimens. Dr. Burness studies these approaches in the laboratory and in clinical trials, with the goal of rapidly translating her laboratory findings into use in the clinic to improve outcomes for breast cancer patients. Dr. Burness is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Breast Cancer in Men, Angiosarcoma, and Paget Disease of the Breast. Dr. Burness is board certified in Internal Medicine and Medical Oncology.

Dr. Carty completed her undergraduate work at Harvard University, graduating magna cum laude, with a degree in Biochemical Sciences. She attended the Albert Einstein College of Medicine in New York where she earned her MD degree. Dr. Carty stayed in New York for her internal medicine residency at Columbia University Medical Center, and moved to the Hospital of the University of Pennsylvania for her Hematology-Oncology fellowship. She remained on staff at the Hospital of the University of Pennsylvania before moving here to Ann Arbor. Dr. Carty is the recipient of a K08 Award for her work in T cell biology and ASH Scholar Award for her research on T cell lymphomas. Dr. Carty is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Carty is board certified in Hematology.

Dr. Erin Cobain is a medical oncologist specializing in the care of patients with breast cancer and inherited cancer predisposition. She serves at Co-Director of the Breast Cancer Clinical Research Team at the Rogel Cancer Center. Dr. Cobain has been on faculty at the University of Michigan since 2016, when she completed her fellowship training. Dr. Cobain specializes in the care of patients with all types of breast cancer and those individuals who are at high risk of developing breast cancer. Dr. Cobain’s research interests include understanding how genetic and genomic testing can be utilized to personalize breast cancer therapy and use of immunotherapy treatments in breast cancer. Dr. Cobain serves as the Principal Investigator of a National Cancer Institute sponsored clinical trial exploring the role of combination chemotherapy and immunotherapy treatment in patients with hormone receptor positive, HER2 negative early-stage breast cancer with high genomic risk. Dr. Cobain is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.